Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Current Deferred Tax Assets (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Current Deferred Tax Assets for 8 consecutive years, with $2.3 million as the latest value for Q1 2022.

  • On a quarterly basis, Current Deferred Tax Assets rose 9.34% to $2.3 million in Q1 2022 year-over-year; TTM through Jan 2022 was $2.3 million, a 9.34% increase, with the full-year FY2022 number at $2.3 million, up 9.34% from a year prior.
  • Current Deferred Tax Assets was $2.3 million for Q1 2022 at Usana Health Sciences, up from $2.1 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $2.3 million in Q1 2022 to a low of $1.7 million in Q4 2019.
  • A 4-year average of $2.0 million and a median of $2.1 million in 2018 define the central range for Current Deferred Tax Assets.
  • Peak YoY movement for Current Deferred Tax Assets: tumbled 32.24% in 2018, then grew 24.24% in 2021.
  • Usana Health Sciences' Current Deferred Tax Assets stood at $2.0 million in 2018, then fell by 18.05% to $1.7 million in 2019, then increased by 24.24% to $2.1 million in 2021, then increased by 9.34% to $2.3 million in 2022.
  • Per Business Quant, the three most recent readings for USNA's Current Deferred Tax Assets are $2.3 million (Q1 2022), $2.1 million (Q1 2021), and $1.7 million (Q4 2019).